The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis
Open Access
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Lipoprotein(a): A Promising Marker for Residual Cardiovascular Risk AssessmentDisease Markers, 2013
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Effects of either Tibolone or Continuous Combined Transdermal Estradiol with Medroxyprogesterone Acetate on Coagulatory Factors and Lipoprotein(a) in MenopauseGynecologic and Obstetric Investigation, 2009
- Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markersJournal of Thrombosis and Haemostasis, 2008
- Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal womenDiabetes, Obesity and Metabolism, 2005
- 1 and 2 mg 17β-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal womenClimacteric, 2005
- Observational Study on the Efficacy of Tibolone in Counteracting Early Carotid Atherosclerotic Lesions in Postmenopausal WomenHormone Research in Paediatrics, 2004
- Testosterone decreases lipoprotein(a) in menThe American Journal of Cardiology, 1996
- Menopause and the Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1987